Physician profile
Robert Borrego
NPI 1821191826
$9,189.74
in general payments reported to CMS, 2019-2025
16 companies · $8,302 in 2025
The $8,302 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $93.35 · 2021: $107 · 2022: $126 · 2023: $214 · 2024: $167 · 2025: $8,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,176 · Travel and Lodging: $897 · Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,175.59 |
| Travel and Lodging | $897.46 |
| Food and Beverage | $610.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,241.24 | 2025 | |
| Kerecis Limited | $220.10 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Janssen Pharmaceuticals, INC | $163.78 | 2020-2023 | Xarelto |
| Smith+Nephew, INC. | $93.86 | 2019-2024 | Collagenase Santyl |
| Kci USA, INC. | $82.43 | 2019 | |
| Penumbra, INC. | $71.21 | 2023 | Indigo System |
| Ucb, INC. | $68.94 | 2019-2022 | |
| Dilon Technologies, INC. | $54.48 | 2023 | Hemoblast Bellows |
| Acera Surgical, INC. | $45.59 | 2021-2024 | Restrata Wound Matrix |
| Pfizer INC. | $43.69 | 2019-2021 | |
| Octapharma USA, INC. | $25.61 | 2025 | Balfaxar |
| Zimmer Biomet Holdings, INC. | $18.03 | 2019 | |
| Acell, INC. | $17.44 | 2020 | |
| Btg International INC. | $16.70 | 2024 | |
| Organogenesis INC. | $14.40 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| My01 INC. | $12.24 | 2025 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Borrego listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.